In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Hosted on MSN4mon
Pfizer’s Weight-Loss Pill is Back. It’s Too Little, Too Late.The company is working on a number of next-generation GLP-1 pills. Plenty of other companies have their own promising weight-loss pill programs. The list includes Viking Therapeutics, Gilead ...
and Eli Lilly & Co. (LLY), are working to develop a weight-loss pill. Jefferies is confident Viking's stock still has plenty of upside. The research team has a $110 price target on the stock ...
Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback